Herein, using bioinformatics and clinical samples, we identified two candidate proteins, folate receptor 1 (FOLR1) and mesothelin (MSLN), that were highly expressed in tumor tissues but exhibited low expression in normal tissues. This evidence concerns the gene MSLN and neoplasm.